Acute Lymphoblastic Leukemia, Pediatric Clinical Trial
Official title:
Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia
Assessment of of the biological effects of curcumin on microbiota in children with acute lymphoblastic leukemia
Assessment of the safety of curcumin, which is the most active constituent of the ground rhizome of the Curcuma longa plant, in children with acute lymphoblastic leukemia patients (ALL) in maintenance phase of chemotherapy through the assessment of the any reported adverse event (AE). And assessment of the curcumin effect on health by eliminating intestinal microflora dysbiosis ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03676504 -
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT05622682 -
Vaccine Immune Recovery After Leukemia
|
||
| Not yet recruiting |
NCT05029531 -
Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)
|
Phase 3 | |
| Not yet recruiting |
NCT06107478 -
Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"
|
||
| Recruiting |
NCT05809284 -
Determining the Mechanisms of Loss of CAR T Cell Persistence
|
||
| Recruiting |
NCT04049383 -
CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL
|
Phase 1 | |
| Active, not recruiting |
NCT04472286 -
Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors
|
||
| Completed |
NCT05973032 -
MRD Detection by NGS in Pediatric B-ALL
|
||
| Completed |
NCT05032716 -
EFFECT OF TREADMILL TRAINING ON BALANCE AFTER CHEMOTHERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
|
N/A | |
| Recruiting |
NCT03035344 -
Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
|
N/A | |
| Terminated |
NCT03705507 -
International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04325841 -
Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children
|
Phase 2 | |
| Active, not recruiting |
NCT03020030 -
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
|
Phase 3 | |
| Not yet recruiting |
NCT06257394 -
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
|
Phase 2 | |
| Active, not recruiting |
NCT03157323 -
Low GI Diet in Children and Adolescents With ALL
|
N/A | |
| Recruiting |
NCT04996160 -
Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
|
Phase 1 | |
| Not yet recruiting |
NCT06421155 -
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
|
N/A | |
| Recruiting |
NCT03643276 -
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
|
Phase 3 | |
| Recruiting |
NCT06074666 -
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
|
N/A | |
| Active, not recruiting |
NCT04088864 -
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
|
Phase 1 |